Mostrando 5 resultados de: 5
Publisher
PLoS ONE(2)
JAMA - Journal of the American Medical Association(1)
Journal of Critical Care(1)
Scientific reports(1)
Área temáticas
Enfermedades(4)
Problemas sociales y servicios a grupos(3)
Medicina forense; incidencia de enfermedades(2)
Medicina y salud(2)
Farmacología y terapéutica(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(5)
ODS 17: Alianzas para lograr los objetivos(4)
ODS 9: Industria, innovación e infraestructura(1)
Origen
scopus(5)
Clinical characteristics, systemic complications, and in-hospital outcomes for patients with COVID-19 in Latin America. LIVEN-Covid-19 study: A prospective, multicenter, multinational, cohort study
ArticleAbstract: Purpose The COVID-19 pandemic has spread worldwide, and almost 396 million people have been infectedPalabras claves:Autores:Aguilar Á., Angel J.M., Aponte C.V., Arango A.J., Arias L.F.M., Ayala A.L., Bastidas A., Bayona A.V., Birri N.R., Bravo J.V., Bravo L., Bruhn A., Buitrago R., Bustos I.G., Cabrera M.V.M., Caceres E.L., Calderón L.E., Carvajal V.E.P., Casanova J.P.M., Castro-Lara J., Chaar A.J., Chávez-Villegas J., Cruz J.D., Cucunubo L., de los Angeles Caiza Mosquera S., Díaz A.M., Espinosa M.A.J., Estenssoro E., Estrada C.A., Forero-Carreño C., Franco F., Freire H.A.S., Friedman G., Fuentes Y.V., Galindo M.A.T., Gallegos X.A.N., Gamboa E., García F., García L., García-Gallo E., Gomez S., Gorordo-Delsol L.A., Hernandez G., Holguin D., Ibáñez-Prada E.D., López-Reveles L.A., Loudet C., Lozada J., Luis Javier Unigarro, Mamani L.F., Mantilla K.A., Manuel Jibaja, Maraschin F., Martín-Loeches I., Martinez L.E.T., Moncayo J.V., Montaño G.S., Morales E.S.E., Moya H.H., Muñoz C.S., Narváez P.O., Nin Vaeza N., Ortíz G., Ortíz V., Ospina-Tascón G.A., Pabón L., Palma D.A.M., Parra-Tanoux D., Peláez C., Picoita F., Pinedo J.A., Poveda M., Quevedo V.C., Ramirez P., Ramírez V., Reyes L.F., Rodríguez A., Rodríguez F., Romero C., Saenz M.G., Saenz-Valcarcel M., Sánchez A.R.B., Sanchez F.R., Sánchez H., Sánchez P., Saucedo L.M., Serrano-Mayorga C.C., Silva E., Solis J.A.C., Troya J.A.M., Trujillo D., Tutillo D.R.M., Vargas N.G.R., Varón-Vega F., Vera-Alarcon M., Vinueza L.E.M., Yupa M.L.Fuentes:scopusEarly rise in central venous pressure during a spontaneous breathing trial: A promising test to identify patients at high risk of weaning failure?
ArticleAbstract: Background The spontaneous breathing trial (SBT) assesses the risk of weaning failure by evaluatingPalabras claves:Autores:Alegría L., Aquevedo A., Bakker J., Berrutti D., Bruhn A., Carpio D., Castro R., Dubo S., García M.F., Godoy K., Hernandez G., Hidalgo C., Labra C., Lagos R., Manuel Jibaja, Peláez C., Picoita F., Ramírez V., Tobar M., Valenzuela E.D.Fuentes:scopusEffect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality among Patients with Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial
Conference ObjectAbstract: Importance: Abnormal peripheral perfusion after septic shock resuscitation has been associated withPalabras claves:Autores:Alegría L., Bakker J., Castro R., Cavalcanti A.B., Cecconi M., Damiani L.P., Diego Barahona, Dubin A., Estenssoro E., Fernández P., Ferri G., Friedman G., Hernandez G., Hurtado J., Manuel Jibaja, Ospina-Tascón G.A., Pairumani R., Teboul J.L., Vladimir Granda-LunaFuentes:scopusDexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19
ArticleAbstract: Purpose: Dexamethasone is the only drug that has consistently reduced mortality in patients with COVPalabras claves:covid-19, Critical care, Dexamethasone, Pneumonia, Severe COVID-19Autores:Albaya-Moreno A., Bastidas A., Bodí M., Díaz A.M., Díaz E., Estella A., Ferrer R., Fuentes Y.V., García-Gallo E., Hernandez G., Jorge-García R., Loza-Vazquez A., Manuel Jibaja, Martín-Loeches I., Moreno G., Ospina-Tascón G.A., Parra-Tanoux D., Reyes L.F., Rodríguez A.H., Sancho I., Silva E., Socías L., Solé-Violán J., Vera-Alarcon M.Fuentes:scopusRisk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study
ArticleAbstract: Around one-third of patients diagnosed with COVID-19 develop a severe illness that requires admissioPalabras claves:Autores:Albaya-Moreno A., Bastidas A., Bodí M., Díaz A.M., Díaz E., Duque S., Estella A., Ferrer R., Figueroa W., Fuentes Y.V., García-Gallo E., Hernandez G., Ibáñez-Prada E.D., Jorge-García R., Loza-Vazquez A., Lozano-Villanueva J.L., Manuel Jibaja, Martín-Loeches I., Moreno G., Ospina-Tascón G.A., Ramirez-Valbuena P.C., Reyes L.F., Rodríguez A., Sancho I., Serrano-Mayorga C.C., Shankar-Hari M., Silva E., Socías L., Solé-Violán J., Varón-Vega F., Vera-Alarcon M.Fuentes:scopus